Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa® technology has powered important advances in ongoing clinical trials for the treatment of Alzheimer’s…
Mission Bio, the pioneer in single-cell DNA and multi-omics analysis, announced the availability of the Tapestri® VCN Assay, the first high-throughput commercial single-cell assay to simultaneously quantify VCN and transduction…
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products. With substantial…
Quanterix Corporation (NASDAQ: QTRX), a company expanding the limits of exploration with ultrasensitive biomarker detection, today announced the validation of a laboratory developed test (LDT) to quantitatively measure phospho-Tau 181…
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the Twist Human…
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has entered into a research…
Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced its Simoa® technology supported a large international and comprehensive study to establish reference…
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of specific synthetic RNA positive…
Everlife Holdings Pte Ltd ("Everlife"), a leading market access and distribution company in India and South East Asia, has announced the completion of its acquisition of Research Instruments Group ("RI"), a leading provider of…
LevitasBio Inc. today announced the launch of their LeviPrep™ and LeviSelect™ product lines. Developed to work with the LeviCell™ system, these solutions streamline the processing of human and mouse tissue and…